Page last updated: 2024-10-24

bupivacaine and Cardiomyopathy, Hypertrophic Obstructive

bupivacaine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 2 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmitto, JD1
Hein, S1
Bräuer, A1
Popov, AF1
Quintel, M1
Schöndube, FA1
Paix, B1
Cyna, A1
Belperio, P1
Simmons, S1

Other Studies

2 other studies available for bupivacaine and Cardiomyopathy, Hypertrophic Obstructive

ArticleYear
Perioperative myocardial infarction after cesarean section in a young woman with hypertrophic obstructive cardiomyopathy.
    Acta anaesthesiologica Scandinavica, 2008, Volume: 52, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local;

2008
Epidural analgesia for labour and delivery in a parturient with congenital hypertrophic obstructive cardiomyopathy.
    Anaesthesia and intensive care, 1999, Volume: 27, Issue:1

    Topics: Adult; Amides; Analgesia, Epidural; Analgesia, Obstetrical; Anesthetics, Local; Bupivacaine; Cardiom

1999